drugset
drugset / Trial / NCT04418388

Pharmacokinetics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women

NCT04418388 ↗

Phase 1 Completed 36 enrolled Pharmbio Korea Co., Ltd.
Non-randomizedSequentialOpen-labelTreatment

Summary

The primary objective of this study is to assess the pharmacokinetic characteristics after a single dose of oral PBK-1801 in healthy Korean women for preparing the bridging data for Koreans.

Timeline

Start
2019-10-24
Primary completion
2019-12-03
Completion
2019-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject PBK-1801 Unknown — Oral

Indications

No indication recorded.